Hap Trading, LLC Xenon Pharmaceuticals Inc. Put Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$28.7 - $46.46 $574,000 - $929,200	20,000 New	20,000 $2.09 Million
Q2 2022 Aug 12, 2022	SELL	$25.44 - $35.16 $508,800 - $703,199	-20,000 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$25.09 - $33.13 $30,108 - $39,756	-1,200 Reduced 5.66%	20,000 $23,000
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $65,520 - $148,680	4,200 Added 24.71%	21,200 $82,000
Q3 2021 Nov 10, 2021	BUY	$14.86 - $19.45 $72,814 - $95,305	4,900 Added 40.5%	17,000 $112,000
Q2 2021 Aug 11, 2021	BUY	$16.81 - $20.0 $203,400 - $242,000	12,100 New	12,100 $91,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.